Glutathione (GMP)

Glutathione (GMP) — GMP Pharmaceutical Grade

Glutathione (GMP) is manufactured under strict Good Manufacturing Practice (GMP) pharmaceutical standards, ensuring absolute sterility, potency, and batch-to-batch consistency for clinical-grade research and application.

Pharmaceutical Specifications

Parameter	Value
Molecular Formula	C10H17N3O6S
Molecular Mass	307.3 g/mol
Quality Grade	GMP Pharmaceutical Grade
Appearance	Clear injectable solution

Figure 1: Glutathione (GMP) Clinical Mechanism

Clinical Mechanism of Action

Pharmaceutical-grade pathway delivering its primary therapeutic effect:

1. Operates as the body's absolute master intracellular antioxidant tripeptide (Glu-Cys-Gly).
2. Directly conjugates to and neutralizes the most dangerous reactive oxygen species within seconds.
3. Recycles spent Vitamin C and Vitamin E back to their active, protective conformations.
4. Drives Phase II liver detoxification — physically binding to toxins for renal clearance.
5. Prevents the lethal accumulation of lipid peroxides that destroy cellular membranes.

Figure 2: Clinical Efficacy Metrics

Primary Clinical Outcomes

• Outcome 1: The single most critical molecule for total systemic detoxification and liver protection.
• Outcome 2: IV administration bypasses the near-total destruction oral glutathione suffers in the gut.
• Outcome 3: Massively reduces oxidative damage markers within 24 hours of pharmaceutical-grade infusion.

The Master Antioxidant: Biochemical Role

Glutathione (GSH) is a tripeptide (L-glutamate–L-cysteine–glycine) present in every human cell at millimolar concentrations. It serves as the primary intracellular antioxidant and is the essential cofactor for glutathione peroxidase and glutathione S-transferase enzyme families. The thiol group on its cysteine residue acts as a reducing agent, neutralizing reactive oxygen species (ROS), peroxides, and electrophilic xenobiotics. Hepatocytes contain the highest concentration of GSH in the body, reflecting the liver’s central role in detoxification.

1. GSH directly scavenges hydroxyl radicals, superoxide anion, and singlet oxygen through its sulfhydryl group.
2. Glutathione peroxidase uses GSH to reduce hydrogen peroxide (H&sub2;O&sub2;) and lipid hydroperoxides, preventing membrane damage.
3. The glutathione S-transferase family conjugates GSH to electrophilic toxins, rendering them water-soluble for renal excretion.
4. GSH recycles oxidized vitamins C and E back to their active forms, maintaining the broader antioxidant network.
5. Intracellular GSH levels decline 10–15% per decade after age 40, correlating with increased oxidative damage markers.

Clinical Research Applications

• Hepatoprotection: IV glutathione has been studied as adjunctive therapy in acetaminophen toxicity, alcoholic liver disease, and non-alcoholic steatohepatitis (NASH) models.
• Skin Lightening: Randomized controlled trials have demonstrated dose-dependent melanin index reduction via inhibition of tyrosinase, the rate-limiting enzyme in melanogenesis.
• Parkinson’s Disease: Pilot studies show IV GSH may transiently improve motor scores in early-stage PD, likely through dopaminergic neuron protection from oxidative stress.
• Chemotherapy Support: GSH has been investigated for reduction of cisplatin-induced nephrotoxicity and peripheral neuropathy without compromising antitumor efficacy.
• Dosing Research: Typical IV research protocols use 600–1500 mg diluted in normal saline, administered over 15–30 minutes, 1–3 times weekly.